The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Loss of function of the maternally inherited allele for the UBE3A ubiquitin ligase gene causes Angelman syndrome (AS), which is characterized by severe neurological impairment and motor dysfunction. In addition, UBE3A lies within chromosome 15q11-q13 region, where maternal, but not paternal, duplications cause autism. The UBE3A gene product, E6-AP, has been shown to function both as an E3 ligase in the ubiquitin proteasome pathway and as a transcriptional coactivator. However, the specific role of E6-AP in the brain, or how loss of function of E6-AP results in AS, is unclear. Herein, we show, using a recombinant transgenic mouse expressing a Ube3a(YFP) fusion gene, that the maternal Ube3a(YFP) allele is upregulated and preferentially expressed in neurons, and that the fusion protein, E6-AP:YFP, is enriched in the nucleus and dendrites in vivo. We also show that E6-AP:YFP localizes to the nucleus and to presynaptic and postsynaptic compartments in cultured hippocampal neurons. Furthermore, we show that cerebellar Purkinje cell number and dendritic branching are not affected in Ube3a maternal-deficient mice, but that dendritic spine development, including spine morphology, number and length, is affected on cerebellar Purkinje cells and on pyramidal neurons in the hippocampus and cortex. Collectively, these data suggest that the neurological deficits observed in AS patients and in AS mice may result from specific abnormalities in synaptic development and/or plasticity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“UBE3A encodes an E3 ubiquitin ligase whose maternal deficiency reduces dendritic spine density and length in cerebellar and hippocampal pyramidal neurons45, suggesting a potential link between Angelman syndrome, autism and altered synaptic structure.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [45]
In the citing paper
“The Angelman syndrome mouse, which lacks the maternal UBE3A gene, displays motor deficits, impaired context-dependent learning, impaired plasticity and altered spine density on hippocampal and cortical pyramidal neurons45,85.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [45]
In the citing paper
“In the cerebellum, cell density and dendritic complexity are unaffected in Ube3am−/p+ mice [86].”
From Autism spectrum disorder: neuropathology and animal models (2017) · cites this paper as [86]
In the citing paper
“spine density is decreased in layer V after 21 days of age [86, 196, 312]”
From Autism spectrum disorder: neuropathology and animal models (2017) · cites this paper as [86]
Citations
Cites
Abnormal dendritic spines in fragile X knockout mice: Maturation and pruning deficits
Comery, T. A., Harris, J. B., Willems, P. J., Oostra, B. A., Irwin, S. A., Weiler, I. J., & Greenough, W. T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5401 · Cited by 1,046
Jiang, Y.-H., Armstrong, D., Albrecht, U., Atkins, C. M., Noebels, J. L., Eichele, G., Sweatt, J. D., & Beaudet, A. L. (1998) · Neuron · doi:10.1016/s0896-6273(00)80596-6 · Cited by 852 · cited 4×
“2 ES cells as described previously (9).”
BackgroundResultInfluentialSelf-citation(1997) · PubMed · Cited by 645
Angelman syndrome 2005: Updated consensus for diagnostic criteria
Williams, C. A., Beaudet, A. L., Clayton‐Smith, J., Knoll, J. H., Kyllerman, M., Laan, L. A., Magenis, R. E., Moncla, A., Schinzel, A. A., Summers, J. A., et al. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31074 · Cited by 627
Self-citationAlbrecht, U., Sutcliffe, J. S., Cattanach, B. M., Beechey, C. V., Armstrong, D., Eichele, G., & Beaudet, A. L. (1997) · Nature Genetics · doi:10.1038/ng0997-75 · Cited by 583
Self-citationUbiquitination Regulates PSD-95 Degradation and AMPA Receptor Surface Expression
Colledge, M., Snyder, E. M., Crozier, R. A., Soderling, J. A., Jin, Y., Langeberg, L. K., Lu, H., Bear, M. F., & Scott, J. D. (2003) · Neuron · doi:10.1016/s0896-6273(03)00687-1 · Cited by 567 · cited 1×
“The presence of E6-AP at the synapse further supports this idea (20), although we cannot exclude a possible contribution of a nuclear role for E6-AP in regulating the structure and/or function of the synapse.”
BackgroundAbnormal Development of Dendritic Spines in FMR1 Knock-Out Mice
Nimchinsky, E. A., Oberlander, A. M., & Svoboda, K. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-14-05139.2001 · Cited by 560
Learning and Memory and Synaptic Plasticity Are Impaired in a Mouse Model of Rett Syndrome
Moretti, P., Levenson, J. M., Battaglia, F., Atkinson, R., Teague, R., Antalffy, B., Armstrong, D., Arancio, O., Sweatt, J. D., & Zoghbi, H. Y. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2623-05.2006 · Cited by 545
Self-citationAnalysis of neocortex in three males with the Fragile X syndrome
Hinton, V. J., Brown, W. T., Wisniewski, K., & Rudelli, R. D. (1991) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320410306 · Cited by 527
Cummings, C. J., Reinstein, E., Sun, Y., Antalffy, B., Jiang, Y.-H., Ciechanover, A., Orr, H. T., Beaudet, A. L., & Zoghbi, H. Y. (1999) · Neuron · doi:10.1016/s0896-6273(00)81035-1 · Cited by 501
Self-citation
Cited by
Items 201–300 of 459
Hanson, J. E., & Madison, D. V. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-96 · Cited by 27
MeCP2 involvement in the regulation of neuronal -tubulin production
Abuhatzira, L., Shemer, R., & Razin, A. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp048 · Cited by 27
UBE3A regulates the transcription of IRF, an antiviral immunity
Furumai, R., Tamada, K., Liu, X., & Takumi, T. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz019 · Cited by 26
Abnormal sleep physiology in children with 15q11.2-13.1 duplication (Dup15q) syndrome
Saravanapandian, V., Nadkarni, D., Hsu, S.-H., Hussain, S. A., Maski, K. P., Golshani, P., Colwell, C. S., Balasubramanian, S., Dixon, A., Geschwind, D. H., et al. (2021) · Molecular Autism · doi:10.1186/s13229-021-00460-8 · Cited by 26
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons
Lopez, S. J., Dunaway, K. W., Islam, M. S., Mordaunt, C. E., Ciernia, A. V., Meguro‐Horike, M., Horike, S., Segal, D. J., & LaSalle, J. M. (2017) · Epigenetics · doi:10.1080/15592294.2017.1376151 · Cited by 26
HAP1 is an in vivo UBE3A target that augments autophagy in a mouse model of Angelman syndrome
Wang, T., Wang, J., Wang, J., Mao, L., Tang, B., Vanderklish, P. W., Liao, X., Xiong, Z., & Liao, L. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104585 · Cited by 26
Hayrapetyan, V. Y., Castro, S., Sukharnikova, T., Yu, C., Cao, X., Jiang, Y., & Yin, H. H. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12442 · Cited by 26
Correction: Impairment of TrkB-PSD-95 Signaling in Angelman Syndrome
Cao, C., Rioult-Pedotti, M. S., Migani, P., Yu, C. J., Tiwari, R. K., Parang, K., Spaller, M. R., Goebel, D. J., & Marshall, J. (2013) · PLoS Biology · doi:10.1371/annotation/f32bc670-c9cf-4bb0-9376-cd8cfd1053c1 · Cited by 26
The neurobiology of mouse models syntenic to human chromosome 15q
Takumi, T. (2011) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-011-9088-1 · Cited by 25
Liu, Y., Johe, K. K., Sun, J., Hao, X., Wang, Y., Bi, X., & Baudry, M. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.10.038 · Cited by 25
Historical perspective and progress on protein ubiquitination at glutamatergic synapses
Mabb, A. M. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108690 · Cited by 25
Epilepsy in Children - Clinical and Social Aspects
Gadže, Ž. P. (2011) · InTech eBooks · doi:10.5772/1140 · Cited by 25
Tonazzini, I., Meucci, S., van Woerden, G. M., Elgersma, Y., & Cecchini, M. G. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201500815 · Cited by 24
mTOR-Dependent Spine Dynamics in Autism
Chaudry, S., & Vasudevan, N. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.877609 · Cited by 24
Weissman, J., Naidu, S., & Bjornsson, H. T. (2014) · Seminars in Neurology · doi:10.1055/s-0034-1386763 · Cited by 24
Fuentealba, C., Fiedler, J. L., Peralta, F. A., Avalos, A. M., Aguayo, F. I., Morgado-Gallardo, K. P., & Aliaga, E. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00261 · Cited by 24
Tonazzini, I., van Woerden, G. M., Masciullo, C., Mientjes, E., Elgersma, Y., & Cecchini, M. G. (2019) · Molecular Autism · doi:10.1186/s13229-019-0293-1 · Cited by 24
A PSD-95 peptidomimetic mitigates neurological deficits in a mouse model of Angelman syndrome
Lau, K. A., Yang, X., Rioult-Pedotti, M. S., Tang, S., Appleman, M., Zhang, J., Tian, Y., Marino, C., Yao, M., Jiang, Q., et al. (2023) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2023.102513 · Cited by 23
Genetic and Epigenetic Dysregulation of Imprinted Genes In The Brain
Kernohan, K. D., & Bérubé, N. G. (2010) · Epigenomics · doi:10.2217/epi.10.61 · Cited by 23
Baptista, M. S., Duarte, C. B., & Maciel, P. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0946-0 · Cited by 23
The Ubiquitinated Axon: Local Control of Axon Development and Function by Ubiquitin
Pinto, M. J., Tomé, D., & Almeida, R. D. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.2251-20.2021 · Cited by 24
Ritchie, F. D., & Lizarraga, S. B. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.989109 · Cited by 22
Pharmacological therapies for Angelman syndrome
Tan, W., & Bird, L. M. (2016) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-015-0408-z · Cited by 22
Peralta, F. A., Fuentealba, C., Fiedler, J. L., & Aliaga, E. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5529 · Cited by 22
Folci, A., Mirabella, F., & Fossati, M. (2020) · eNeuro · doi:10.1523/eneuro.0137-20.2020 · Cited by 22
AntimiR targeting of microRNA-134 reduces seizures in a mouse model of Angelman syndrome
Campbell, A., Morris, G., Sanfeliu, A., Augusto, J., Langa, E., Kesavan, J., Nguyen, T. N., Conroy, R. M., Worm, J., Kielpinski, L. J., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.04.009 · Cited by 22
GABRB3, epilepsy, and neurodevelopment
Tanaka, M., DeLorey, T. M., Delgado‐Escueta, A. V., & Olsen, R. W. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02863.x · Cited by 22
Tordjman, S., Cohen, D., Coulon, N., Anderson, G. M., Botbol, M., Canitano, R., & Roubertoux, P. L. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.01.030 · Cited by 22
Moreira-de-Sá, A., Gonçalves, F. Q., Lopes, J. P., Silva, H. B. L., Tomé, Â. R., Cunha, R. A., & Canas, P. M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105137 · Cited by 21
Epigenetics in rare neurological diseases
Roberts, C.-T., Arezoumand, K. S., Shahib, A. K., Davie, J., & Rastegar, M. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1413248 · Cited by 20
Bazick, H., Mao, H., Niehaus, J. K., Wolter, J. M., & Zylka, M. J. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.09.032 · Cited by 20
Genomic imprinting does not reduce the dosage of UBE3A in neurons
Hillman, P., Christian, S., Doan, R. N., Cohen, N. D., Konganti, K., Douglas, K. C., Wang, X., Samollow, P. B., & Dindot, S. V. (2017) · Epigenetics & Chromatin · doi:10.1186/s13072-017-0134-4 · Cited by 20
Self-citationBerg, E. L., Petkova, S. P., Born, H. A., Adhikari, A., Anderson, A. E., & Silverman, J. L. (2021) · Molecular Autism · doi:10.1186/s13229-021-00467-1 · Cited by 20
Gene Therapy for Angelman Syndrome: Contemporary Approaches and Future Endeavors
Tsagkaris, C., Papakosta, V., Miranda, A. V., Zacharopoulou, L., Danilchenko, V. Y., Matiashova, L., & Dhar, A. (2020) · Current Gene Therapy · doi:10.2174/1566523220666200107151025 · Cited by 20
Aria, F., Pandey, K. R., & Alberini, C. M. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.11.016 · Cited by 19
Imprinting effects of UBE3A loss on synaptic gene networks and Wnt signaling pathways
Lopez, S. J., Laufer, B. I., Beitnere, U., Berg, E. L., Silverman, J. L., O’Geen, H., Segal, D. J., & LaSalle, J. M. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz221 · Cited by 19
Syding, L. A., Kubik‐Zahorodna, A., Nickl, P., Novosadová, V., Kopkanova, J., Kašpárek, P., Procházka, J., & Sedláček, R. (2022) · Cells · doi:10.3390/cells11182815 · Cited by 18
Spatial and temporal silencing of the human maternal UBE3A gene
Daily, J., Smith, A., & Weeber, E. J. (2012) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2012.03.006 · Cited by 18
Enhanced Nociception in Angelman Syndrome Model Mice
McCoy, E. S., Taylor‐Blake, B., Aita, M., Simon, J. M., Philpot, B. D., & Zylka, M. J. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1018-17.2017 · Cited by 18
Angelman syndrome: advancing the research frontier of neurodevelopmental disorders
Philpot, B. D., Thompson, C. E., Franco, L., & Williams, C. A. (2011) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-010-9066-z · Cited by 17
Lefort, R. (2015) · Neurotherapeutics · doi:10.1007/s13311-014-0328-4 · Cited by 17
“Indeed, in the last few decades, multiple lines of evidence have shown that disruptions in dendritic spine shape, size, or number invariably accompany various brains disorders, such as schizophrenia [6–9], Angelman syndrome [10], and Rett syndrome [11–13], and may be even be a characteristic feature of traumatic brain…”
BackgroundAutism Spectrum Disorder: The Cerebellum, Genes, and Pathways
D’Mello, S. R. (2025) · Neurology International · doi:10.3390/neurolint17100173 · Cited by 17
Terashima, H., Minatohara, K., Maruoka, H., & Okabe, S. (2022) · Microscopy · doi:10.1093/jmicro/dfab039 · Cited by 17
Ubiquitin-protein ligase E3A (UBE3A) mediation of viral infection and human diseases
Chaudhary, P., Proulx, J. M., & Park, I.-W. (2023) · Virus Research · doi:10.1016/j.virusres.2023.199191 · Cited by 17
Roy, B., Amemasor, E., Hussain, S., & Castro, K. (2023) · Diseases · doi:10.3390/diseases12010007 · Cited by 17
Towards an understanding of Angelman syndrome in mice studies
Yang, X. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24576 · Cited by 17
Godavarthi, S. K., Dey, P. N., Sharma, A., & Jana, N. R. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.07.103 · Cited by 17
Mono-ubiquitination of Rabphilin 3A by UBE3A serves a non-degradative function
Avagliano Trezza, R., Punt, A. M., Mientjes, E., van den Berg, M., Zampeta, F. I., de Graaf, I. J., van der Weegen, Y., Demmers, J. A. A., Elgersma, Y., & Distel, B. (2021) · Scientific Reports · doi:10.1038/s41598-021-82319-9 · Cited by 16
Roy, B., Han, J., Hope, K. A., Peters, T. L., Palmer, G. E., & Reiter, L. T. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.03.021 · Cited by 16
Marland, J. R. K., Pan, D., & Buttery, P. C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.166728 · Cited by 16
Geerts‐Haages, A., Bossuyt, S. N. V., den Besten, I., Brüggenwirth, H. T., van der Burgt, I., Yntema, H. G., Punt, A. M., Brooks, A. S., Elgersma, Y., Distel, B., et al. (2020) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1481 · Cited by 16
Summers, J. (2012) · Developmental Neurorehabilitation · doi:10.3109/17518423.2012.676101 · Cited by 16
Erickson, R. P. (2016) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2015.12.002 · Cited by 15
Kim, J., Lee, B., Kim, D., Yeon, J. G., Lee, J., Park, Y., Yuna, L., Lee, S., Lee, S., & Lee, J. W. (2018) · Hepatology · doi:10.1002/hep.30284 · Cited by 15
Aberrant aggressive behavior in a mouse model of Angelman syndrome
Simchi, L., & Kaphzan, H. (2021) · Scientific Reports · doi:10.1038/s41598-020-79984-7 · Cited by 14
A patogênese genética e molecular da síndrome de Angelman
Maris, A. F., & Trott, A. (2011) · Jornal Brasileiro de Psiquiatria · doi:10.1590/s0047-20852011000400014 · Cited by 14
Cerebellar and Striatal Pathologies in Mouse Models of Autism Spectrum Disorder
Peter, S., Zeeuw, C. I. D., Boeckers, T. M., & Schmeißer, M. J. (2017) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-319-52498-6_6 · Cited by 15
Genetic variation of UBE3A is associated with schizotypy in a population of typical individuals
Salminen, I., Read, S., Hurd, P. L., & Crespi, B. J. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.03.019 · Cited by 14
Circadian Rhythms and Sleep Are Dependent Upon Expression Levels of Key Ubiquitin Ligase Ube3a
Shi, S.-Q., Mahoney, C. E., Houdek, P., Zhao, W., Anderson, M. P., Zhuo, X., Beaudet, A. L., Sumová, A., Scammell, T. E., & Johnson, C. H. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.837523 · Cited by 14
Self-citationSynaptic Plasticity as a Therapeutic Target in the Treatment of Autism-related Single-gene Disorders
Pignatelli, M., Feligioni, M., Piccinin, S., Molinaro, G., Nicoletti, F., & Nisticò, R. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319360008 · Cited by 14
Zhu, L., Zhao, D., & Yang, L. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt020 · Cited by 14
Unraveling the Roles of UBE3A in Neurodevelopment and Neurodegeneration
Yang, X., & Huang, Y. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052304 · Cited by 14
Loss of UBE3A impacts both neuronal and non-neuronal cells in human cerebral organoids
Estridge, R. C., Yagci, Z. B., Sen, D., Johnson, T. J., Kelkar, G. R., Ptacek, T., Simon, J. M., & Keung, A. J. (2025) · Communications Biology · doi:10.1038/s42003-025-08262-x · Cited by 13
Gene editing in monogenic autism spectrum disorder: animal models and gene therapies
Wang, N., Lv, L., Huang, X., Shi, M., Dai, Y., Wei, Y., Xu, B., Fu, C., Huang, H., Shi, H., et al. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1043018 · Cited by 13
Precision Medicine in Angelman Syndrome
Manssen, L., Krey, I., Gburek‐Augustat, J., von Hagen, C., Lemke, J. R., Merkenschlager, A., Weigand, H., & Makowski, C. C. (2024) · Neuropediatrics · doi:10.1055/a-2399-0191 · Cited by 12
McGee, S. R., Rajamanickam, S., Adhikari, S., Falayi, O. C., Wilson, T. A., Shayota, B. J., Coleman, J. A. C., Skinner, C. D., Caylor, R. C., Stevenson, R. E., et al. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac200 · Cited by 12
Azadiradione up-regulates the expression of parvalbumin and BDNF via Ube3a
Jana, S., Giri, B., Das, S., Manna, A., Mandal, S. C., & Jana, N. R. (2023) · Gene · doi:10.1016/j.gene.2023.148081 · Cited by 12
Douglas, K. C., Wang, X., Jasti, M., Wolff, A., VandeBerg, J. L., Clark, A. G., & Samollow, P. B. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-89 · Cited by 12
The ubiquitin-proteasome system functionally links neuronal Tomosyn-1 to dendritic morphology
Saldate, J. J., Shiau, J., Cazares, V. A., & Stuenkel, E. L. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.815514 · Cited by 12
Musi, C. A., Agrò, G., Buccarello, L., Camuso, S., & Borsello, T. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104812 · Cited by 12
Bioinformatics analyses show dysregulation of calcium-related genes in Angelman syndrome mouse model
Panov, J., & Kaphzan, H. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105180 · Cited by 12
Alterations of synaptic plasticity in Angelman syndrome model mice are rescued by 5-HT7R stimulation
Pizzella, A., Penna, E., Liu, Y., Abate, N., Lacivita, E., Leopoldo, M., Perrone‐Capano, C., Crispino, M., Baudry, M., & Bi, X. (2024) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2024.102684 · Cited by 11
Emerging roles for E3 ubiquitin ligases in neural development and disease
Hale, M., & Bashaw, G. J. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1557653 · Cited by 11
Epigenetics, Brain and Behavior
Sassone‐Corsi, P., & Christen, Y. (2012) · Research and perspectives in neurosciences · doi:10.1007/978-3-642-27913-3 · Cited by 11
Jourdain, J., Capitan, A., Saintilan, R., Hozé, C., Fouéré, C., Fritz, S., Boichard, D., & Barbat, A. (2024) · Journal of Dairy Science · doi:10.3168/jds.2023-24632 · Cited by 10
Swimming exercise is a promising early intervention for autism‐like behavior in Shank3 deletion rats
Xu, D., Meng, Y., An, S., Meng, W., Li, H., Zhang, W., Xue, Y., Lan, X., Wang, X., Li, M., et al. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13920 · Cited by 10
Schultz, M. N., & Crawley, J. N. (2020) · Learning & Memory · doi:10.1101/lm.051201.119 · Cited by 10
Genetic Counseling: Preconception, Prenatal and Perinatal
Milunsky, A., & Milunsky, J. M. (2009) · Wiley eBooks · doi:10.1002/9781444314342.ch1 · Cited by 10
Angelman Syndrome: Finding the Lost Arc
Tai, H., & Schuman, E. M. (2010) · Cell · doi:10.1016/j.cell.2010.02.019 · Cited by 10
Neocortical development as an evolutionary platform for intragenomic conflict
Lewitus, É., & Kalinka, A. T. (2013) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2013.00002 · Cited by 9
The Drosophila melanogaster homolog of UBE3A is not imprinted in neurons
Hope, K. A., LeDoux, M. S., & Reiter, L. T. (2016) · Epigenetics · doi:10.1080/15592294.2016.1214783 · Cited by 9
Mezzena, R., Masciullo, C., Antonini, S., Cremisi, F., Scheffner, M., Cecchini, M. G., & Tonazzini, I. (2020) · Nanotechnology · doi:10.1088/1361-6528/abbb03 · Cited by 9
Stem cell models of Angelman syndrome
dos Santos, J. C., Appleton, C., Mateus, F. C., Covas, R., Bekman, E., & da Rocha, S. T. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1274040 · Cited by 9
Sleep disturbance in Angelman syndrome patients
Qu, S., Wang, J., Guan, X., Song, C., & Wang, Y. (2024) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-024-03154-5 · Cited by 9
Modeling neurodegenerative and neurodevelopmental disorders in theDrosophilamushroom body
Stahl, A., & Tomchik, S. M. (2024) · Learning & Memory · doi:10.1101/lm.053816.123 · Cited by 9
TC10β/CDC42 GTPase activating protein is required for the growth of cortical neuron dendrites
Shen, P.-C., Xu, D., Liu, J.-W., Li, K., Lin, M.-H., Wang, H.-T., Wang, R., & Zheng, J. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.053 · Cited by 9
Human Neuroplasticity and Education
(2011) · Libreria Editrice Vaticana eBooks · doi:10.65398/xvgl8135 · Cited by 9
Rayi, P. R., & Kaphzan, H. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.670998 · Cited by 8
Pharmacotherapeutic management of seizures in patients with Angleman Syndrome
Samanta, D. (2022) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2022.2105141 · Cited by 8
Spine morphogenesis and synapse formation in tubular sclerosis complex models
Shimada, T., & Yamagata, K. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1019343 · Cited by 8
Huie, E. Z., Yang, X., Rioult-Pedotti, M. S., Tran, K., Monsen, E. R., Hansen, K. M., Erickson, M. A., Naik, M. T., Yotova, A. Y., Banks, W. A., et al. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-02020-z · Cited by 8
Dendrites in Autism Spectrum Disorders
Martínez‐Cerdeño, V., Maezawa, I., & Jin, L. (2016) · Springer eBooks · doi:10.1007/978-4-431-56050-0_20 · Cited by 8
Hope, K. A., Johnson, D. L., Miller, P. W., López‐Ferrer, D., Kakhniashvili, D. G., & Reiter, L. T. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104879 · Cited by 8
Shi, S.-Q., & Johnson, C. H. (2018) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2018.06.006 · Cited by 8
Imprinting analysis of the mouse chromosome 7C region in DNMT1-null embryos
Nakagaki, A., Osanai, H., & Kishino, T. (2014) · Gene · doi:10.1016/j.gene.2014.10.006 · Cited by 8
Bazick, H., James, L. M., Taylor‐Blake, B., Wolter, J. M., & Zylka, M. J. (2025) · Gene Therapy · doi:10.1038/s41434-025-00582-1 · Cited by 7
The role of glia in the dysregulation of neuronal spinogenesis in Ube3a-dependent ASD
Gardner, Z., Holbrook, O., Tian, Y., Odamah, K., & Man, H. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114756 · Cited by 7
Biagioni, M., Baronchelli, F., & Fossati, M. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106669 · Cited by 7
Dendrites: A Key Structural Element of Neurons
Rollenhagen, A., & Lübke, J. H. R. (2012) · Springer eBooks · doi:10.1007/978-1-4614-1997-6_11 · Cited by 7
Characterizing spine issues: If offers novel therapeutics to Angelman syndrome
Yang, X. (2020) · Developmental Neurobiology · doi:10.1002/dneu.22757 · Cited by 7
Metadata
- Authors
- Dindot, S. V., Antalffy, B. A., Bhattacharjee, M. B., & Beaudet, A. L.
- Affiliations
- Baylor College of Medicine (US)
- Corresponding author
- Beaudet, A. L.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-09-27
- Volume
- 17
- Issue
- 1
- Pages
- 111-118
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2143860178
- Cited by
- 418
- References
- 35
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 20 · 2023: 13 · 2022: 23 · 2021: 28 · 2020: 31 · 2019: 19 · 2018: 17 · 2017: 20 · 2016: 29 · 2015: 28 · 2014: 27 · 2013: 33 · 2012: 27
- FWCI
- 9.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Institutes of Health (5f32hd049248-02)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD 24064, F32 HD-049248, R01HD037283, P30HD024064)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Angelman syndrome, UBE3A, ubiquitin ligase, maternal inheritance, chromosome 15q11-q13, dendritic spine morphology, synaptic development, Purkinje cells, hippocampal neurons, nuclear localization, transcriptional coactivator, autism spectrum disorder, transgenic mouse model
- MeSH terms
- Animals, Base Sequence, Cell Nucleus, Cells, Cultured, Female, Hippocampus, Humans, Male, Mice, Inbred C57BL, Mice, Transgenic, Purkinje Cells, Recombinant Fusion Proteins, Synapses, DNA Probes, Angelman Syndrome, Mice, Knockout, Genomic Imprinting, Ubiquitin-Protein Ligases, Dendritic Spines, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.